In a study devising the intramuscularly injection of functional dystrophin transgene in six DMD patients, Mendell et al. demonstrated the unexpected presence of circulating CD4+ T lymphocytes against self-dystrophin epitopes in two patients before treatment. This evidence concerns the gene DMD and Duchenne muscular dystrophy.